Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$3.76 - $5.14 $109,983 - $150,350
-29,251 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$4.81 - $8.74 $12,544 - $22,793
-2,608 Reduced 8.19%
29,251 $147,000
Q4 2020

Feb 16, 2021

BUY
$5.03 - $6.31 $42,644 - $53,496
8,478 Added 36.26%
31,859 $167,000
Q3 2020

Nov 12, 2020

BUY
$4.67 - $11.0 $12,543 - $29,546
2,686 Added 12.98%
23,381 $122,000
Q2 2020

Aug 13, 2020

BUY
$3.06 - $7.06 $18,965 - $43,757
6,198 Added 42.75%
20,695 $112,000
Q1 2020

May 14, 2020

SELL
$2.9 - $6.97 $15,981 - $38,411
-5,511 Reduced 27.54%
14,497 $54,000
Q4 2019

Feb 14, 2020

BUY
$6.48 - $8.76 $51,127 - $69,116
7,890 Added 65.11%
20,008 $133,000
Q3 2019

Nov 14, 2019

SELL
$7.7 - $10.42 $155,955 - $211,046
-20,254 Reduced 62.57%
12,118 $94,000
Q2 2019

Aug 14, 2019

SELL
$8.29 - $13.22 $182,686 - $291,329
-22,037 Reduced 40.5%
32,372 $308,000
Q1 2019

May 15, 2019

SELL
$6.82 - $10.27 $22,949 - $34,558
-3,365 Reduced 5.82%
54,409 $448,000
Q4 2018

Feb 14, 2019

SELL
$7.65 - $12.83 $257,024 - $431,062
-33,598 Reduced 36.77%
57,774 $471,000
Q3 2018

Dec 21, 2021

BUY
$7.06 - $12.49 $74,137 - $131,157
10,501 Added 12.98%
91,372 $1.14 Million
Q3 2018

Nov 14, 2018

BUY
$7.06 - $12.49 $32,596 - $57,666
4,617 Added 6.05%
80,871 $1.01 Million
Q2 2018

Apr 21, 2020

BUY
$7.96 - $13.23 $101,147 - $168,113
12,707 Added 20.0%
76,254 $607,000
Q2 2018

Aug 14, 2018

SELL
$7.96 - $13.23 $180,087 - $299,315
-22,624 Reduced 26.25%
63,547 $504,000
Q1 2018

Oct 18, 2019

BUY
$6.6 - $13.91 $59,268 - $124,911
8,980 Added 11.63%
86,171 $880,000
Q1 2018

May 15, 2018

SELL
$6.6 - $13.91 $7,616 - $16,052
-1,154 Reduced 1.47%
77,191 $788,000
Q4 2017

Feb 14, 2018

BUY
$5.89 - $7.21 $278,061 - $340,376
47,209 Added 151.62%
78,345 $506,000
Q3 2017

Nov 14, 2017

BUY
$4.43 - $6.58 $137,932 - $204,874
31,136
31,136 $197,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $96.1M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.